<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29843</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Editorial article</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Передовая статья</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Allele polymorphism of alkaline, acid soluble phosphatase genes and vitamin D-binding protein in postmenopausal osteoporosis</article-title><trans-title-group xml:lang="ru"><trans-title>Аллельный полиморфизм генов щелочной фосфатазы, кислой растворимой фосфатазы и белка, связывающего витамин D, при постклимактерическом остеопорозе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Krylov</surname><given-names>M Yu</given-names></name><name xml:lang="ru"><surname>Крылов</surname><given-names>М Ю</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва; ГУ Институт ревматологии РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Korotkova</surname><given-names>T A</given-names></name><name xml:lang="ru"><surname>Короткова</surname><given-names>Т А</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва; ГУ Институт ревматологии РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Myakotkin</surname><given-names>V A</given-names></name><name xml:lang="ru"><surname>Мякоткин</surname><given-names>В А</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва; ГУ Институт ревматологии РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Benevolenskaya</surname><given-names>L I</given-names></name><name xml:lang="ru"><surname>Беневоленская</surname><given-names>Л И</given-names></name></name-alternatives><bio xml:lang="ru"><p>Москва; ГУ Институт ревматологии РАМН</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ГУ Институт ревматологии РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2004-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2004</year></pub-date><volume>79</volume><issue>5</issue><issue-title xml:lang="en">NO5 (2004)</issue-title><issue-title xml:lang="ru">ТОМ 79, №5 (2004)</issue-title><fpage>61</fpage><lpage>65</lpage><history><date date-type="received" iso-8601-date="2020-04-09"><day>09</day><month>04</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2004, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2004, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2004</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/29843">https://ter-arkhiv.ru/0040-3660/article/view/29843</self-uri><abstract xml:lang="en"><p>Aim. To study polymorphism of genes involved in mechanisms regulating metabolism of bone tissue: alkaline (ALPL) and acid (ACPI) phosphatases, vitamin D-bindingprotein (GC); to ascertain associations of their genotypes and alleles with osteoporosis (OP) and mineral density of spinal and femoral bone tissue (BTMD).
Material and methods. Relevant genetic examination was made in 70 females with OP diagnosed by the WHO criteria (1994) aged 60-79years (mean age 71.0 ± 6.2years) and 51 ОP-free females in the same age interval (mean age 69.0 ± 5.6 years). Polymorphic sites of the genes were examined by polymerase chain reaction. Trinucleotide repeat, ARG105GLN polymorphism of restrictive fragment length (PRFL), [GC, TRH420LYS] PRFL were studied for ALPL gene, ACPI gene and GС gene, respectively.
Results. Association was found between frequencies of genotypes SS, 2F and FS, F allele of GC gene with OP as well as between PRFL of the spine, femur and some GC genotypes in OP women. Genes ALPL and ACPI were not associated with OP.
Conclusion. It is suggested that genotypes SS, 2F and FS have marked functional differences in fixation and transport of vitamin D active metabolites involved in metabolism of bone tissue in OP.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Изучение полиморфизма генов, принимающих участие в механизмах регуляции метаболизма костной ткани: щелочной (ALPL) и кислой (ACPI) фосфатаз, а также белка, связывающего витамин D (GC), и поиск ассоциаций их генотипов и аллелей с остеопорозом (ОП) и с показателями минеральной плотности костной ткани (МПКТ) в области позвоночника и бедренной кости.
Материалы и методы. Обследовали 70 женщин с установленным (согласно критериям ВОЗ, 1994) диагнозом ОП в возрасте от 60 до 79 лет (средний возраст 71,0 +6,2 года) и 51 женщину без ОП в том же возрасте (средний возраст 69,0 ±5,6 года). Для изучения полиморфных участков исследуемых генов использовали полимеразную цепную реакцию: для гена ALPL исследовали тринуклеотидный повтор, для гена ACPI - полиморфизм длин рестриктных фрагментов (ПДРФ) ARGW5GLN, для гена GC - ПДРФ [GC, TRH420LYS]. Результаты. Установлены ассоциация частот генотипов SS, 2F и FS, а также аллеля F гена GC с ОП и связь МПКТ позвоночника и шейки бедренной кости с некоторыми генотипами GCy женщин с ОП. Не обнаружено связи генов ALPL и ACPI с предрасположенностью к ОП. Заключение. Можно предположить, что генотипы SS, 2F и FS имеют выраженные функциональные различия в фиксации и транспортировке активных метаболитов витамина D, участвующих в метаболизме костной ткани при ОП.</p></trans-abstract><kwd-group xml:lang="en"><kwd>GC genotypes</kwd><kwd>association</kwd><kwd>osteoporosis</kwd><kwd>mineral density of bone tissue</kwd><kwd>genetic marker</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>генотипы GC</kwd><kwd>ассоциация</kwd><kwd>остеопороз</kwd><kwd>минеральная плотность костной ткани</kwd><kwd>генетический маркер</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Melton L. J. Epidemiology of hip fractures: implications of the exponential increase with age. Bone '1996; 18: 1215-1218.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Gueguen R., Jouanny P., Guiltemin F. Segregation analysis and variants components analysis of bone mineral density in health families. J. Bone Miner. Res. 1995; 12: 2017-2022.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Seeman E., Hooper J. L., Bach L. A. et al. Reduced bone mass in daughters of women with osteoporosis. N. Engl. J. Med. 1989; 69: 2656-2671.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Soroko S. В., Barrett-Connor E., Edelstein S. L. Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernando study. J. Bone Miner. Res. 1996; 9: 761-769.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Procok N. A., Eisman J. A., Hooper J. L. et al. Genetic determinants of bone mass in adults: a twin study. J. Clin. Invest. 1987; 80: 706-710.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Livshits G., Karasik D., Otremski I., Kobyliansky E. Genes play an important role in bone aging. Am. J. Hum. Biol. 1998; 10: 421-438.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Devoto M., Shimoya K., Caminis J. et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes lp, 2p and 4q. Eur. J. Hum. Genet. 1998; 6: 151-157.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Haussler M. R, Whitfield G. K., Haussler С. A. et al. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. J. Bone Miner. Res. 1998; 13: 325-339.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Coppenhaver D., Knappers F., Schidlow D. et al. Serum concentrations of vitamin D-binding progtein (Group-Specific Component) in cystic fibrosis. Hum. Genet. 1981; 4: 339- 403.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Шварц Т. Я. Витамин D. D-гормон и альфакалшидол: молекулярно-биологические и фармакологические аспекты действия. Остеопороз и остеопатии 1998; 3: 2-6.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Martin Т. J., Dempster D. W. Bone structure and cellular activity. In: Stevenson J. C, Lindsay R., eds. Osteoporosis. London: Chapman &amp; Hall Medical; 1998. 1-28.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Calvo M. S., Eyre D. R., Gundberg С. M. Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev. 1996; 17 (4): 333-363.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Ericson E. F., Brixen K., Charles P. New markers of bone metabolism: clinical use in bone disease. Eur. J. Endocrinol. 1995; 132: 251-263.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Dissing J., Johnsen H. H, Sensabaugh G. F. Human red cell acid phosphatase (ACPI): the amino acid sequence of the two isozymes Bf and Bs encoded by the ACP1*B allele. J. Biol. Chem. 1991; 266: 20619-20625.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Miller S. A., Dykes D. D., Polesky H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16: 12-15.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Braun A., Bichlmaier R., Cleve H. Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types. Hum. Genet. 1992; 89: 401-406.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Brodeur G. Personal communication: Chrmosome 1 STSs. Hum. Mol. Genet. 1993; 2: 401.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Sensabaugh G. F., Lazaruk K. A. A Taq I site identifies the A* allele at the ACPI locus. Ibid. 1079.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Спицын В. А., Титенко Н. В. Субтипы группспецифического компонента сыворотки крови (GC) в норме и при патологии. Генетика 1990; 26 (4): 749-759.</mixed-citation></ref></ref-list></back></article>
